Qin Ning

1997–2026 年に発表

101
論文数
19,080
被引用数
49
h 指数
96
i10 指数

被引用数

Qin Ning の年別被引用数1992 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 4 件2000 年: 被引用 11 件2001 年: 被引用 12 件2002 年: 被引用 7 件2003 年: 被引用 10 件2004 年: 被引用 12 件2005 年: 被引用 10 件2006 年: 被引用 8 件2007 年: 被引用 9 件2008 年: 被引用 12 件2009 年: 被引用 13 件2010 年: 被引用 26 件2011 年: 被引用 21 件2012 年: 被引用 26 件2013 年: 被引用 29 件2014 年: 被引用 18 件2015 年: 被引用 31 件2016 年: 被引用 20 件2017 年: 被引用 48 件2018 年: 被引用 59 件2019 年: 被引用 249 件2020 年: 被引用 2,551 件2021 年: 被引用 1,804 件2022 年: 被引用 907 件2023 年: 被引用 461 件2024 年: 被引用 670 件2025 年: 被引用 266 件2026 年: 被引用 16 件1993〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,809 件、この内訳の 17.2%中国: 引用元論文 1,790 件、この内訳の 17%イギリス: 引用元論文 580 件、この内訳の 5.5%イタリア: 引用元論文 540 件、この内訳の 5.1%インド: 引用元論文 470 件、この内訳の 4.5%ドイツ: 引用元論文 383 件、この内訳の 3.6%スペイン: 引用元論文 344 件、この内訳の 3.3%フランス: 引用元論文 331 件、この内訳の 3.1%カナダ: 引用元論文 308 件、この内訳の 2.9%オーストラリア: 引用元論文 226 件、この内訳の 2.2%ブラジル: 引用元論文 213 件、この内訳の 2%イラン: 引用元論文 193 件、この内訳の 1.8%
0%17.2%その他 31.8%

分野

  • Medicine81.9%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology5.4%
  • Neuroscience1.1%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Nursing0.8%
  • その他3.2%

トピック

  • COVID-19 Clinical Research Studies17%
  • Long-Term Effects of COVID-1910.6%
  • SARS-CoV-2 and COVID-19 Research7.1%
  • Liver Disease Diagnosis and Treatment3%
  • Liver Disease and Transplantation2.6%
  • Hepatitis B Virus Studies2.4%
  • その他57.3%

共著者

全論文

検索で開く
  1. Clinical and immunological features of severe and moderate coronavirus disease 2019

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 5,074

  2. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal ほか 12 名 - Hepatology International 2019 被引用: 889

  3. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

    著者: , , , , , , , , , , , , , , , , , , , , - BMJ 2020 被引用: 4,159

  4. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brajesh Chander Sharma, Manoj Kumar Sharma, Kapil Sharma, Amna Subhan Butt, Soek Siam Tan, Chitranshu Vashishtha, Zeeshan Ahmad Wani, Man‐Fung Yuen, Osamu Yokosuka, the APASL ACLF Working Party - Hepatology International 2014 被引用: 1,496

  5. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

    著者: , , , , , , , , , , , , , - Journal of Clinical Investigation 2021 被引用: 244

  6. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism

    著者: , , , , , , , , , , - Nature Communications 2017 被引用: 187

  7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder

    著者: , , , , , , , , , , - Theranostics 2020 被引用: 105

  8. Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production

    著者: , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2016 被引用: 261

  9. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB

    著者: , , , , , , , , , , , , , , , - Journal of Hepatology 2022 被引用: 100

  10. Acute liver failure: mechanisms of immune-mediated liver injury

    著者: , , , , - Liver International 2010 被引用: 281

  11. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 被引用: 83

  12. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations

    著者: , , , , , , , , , , , , , , , - JCI Insight 2022 被引用: 89

  13. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

    著者: , , , , , , , , - Journal of Hepatology 2014 被引用: 279

  14. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana A. Payawal, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, George Lau, Fazal Karim, Padaki Nagaraja Rao, Richard Moreau, Pratik Jain, P. Bhatia, G. Kumar, Shiv Kumar Sarin - Hepatology International 2017 被引用: 220

  15. Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

    著者: , , , , , , - Frontiers in Immunology 2023 被引用: 47

  16. FGL2–MCOLN3-Autophagy Axis–Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis

    著者: , , , , , , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2022 被引用: 43

  17. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2008 被引用: 762

  18. The role of B cells in COVID-19 infection and vaccination

    著者: , , , , , , , , , , , - Frontiers in Immunology 2022 被引用: 79

  19. Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC

    著者: , , , , , , , , , , , , , , , , , , , , , , - Liver International 2021 被引用: 59

  20. Circulating MOTS-c levels are decreased in obese male children and adolescents and associated with insulin resistance

    著者: , , , , , , , , , - Pediatric Diabetes 2018 被引用: 95

  21. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

    著者: , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 被引用: 85

  22. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

    著者: , , , , , , , , , , - Critical Care 2020 被引用: 198

  23. Trimetazidine prevents macrophage‐mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1

    著者: , , , , , , , - British Journal of Pharmacology 2015 被引用: 123

  24. Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peng Hu, Pisit Tangkijvanich, Lunli Zhang, Zhi Gao, Feng Lin, Thi Tuyet Phuong Le, Jia Shang, Guozhong Gong, Jun Li, Minghua Su, Zhongping Duan, Rosmawati Mohamed, Jin Hou, Jidong Jia - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 120